LAIR‐1 may also participate a critical part in TIME of LGG by regulating the infiltration of immune cells, suggesting that LAIR‐1 might be used as a therapeutic target to regulate the anti‐tumor immune response. This evidence concerns the gene LAIR1 and neoplasm.